<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/188</identifier>
				<datestamp>2024-10-30T19:16:05Z</datestamp>
				<setSpec>aavptbiennial:S1</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Use of Airway Smooth Muscle to Evaluate Anti-Inflammatory and Anti-Asthmatic Agents</dc:title>
	<dc:creator xml:lang="en">Burka, John F.</dc:creator>
	<dc:subject xml:lang="en">on-sterodial anti-inflammatory agents</dc:subject>
	<dc:subject xml:lang="en">anti-asthmatic drugs</dc:subject>
	<dc:subject xml:lang="en">lipoxygenase</dc:subject>
	<dc:subject xml:lang="en">peptidoleukotrienes</dc:subject>
	<dc:subject xml:lang="en">cyclooxygenase</dc:subject>
	<dc:description xml:lang="en">Because non-sterodial anti-inflammatory agents (NSAID) have not been effective anti-asthmatic drugs, it has been implied that lipoxygenase products, particularly the peptidoleukotrienes, are involved in bronchoconstriction and inflammation (2). Indeed, NSAIDs exacerbate asthma in susceptible individuals. However, recent evidence for prostaglandin and thromboxane involvement, either secondary to leukotrienes (i.e. TXA2: ref.4) or as primary mediators (PGD2: ref.5), does not negate a role for cyclooxygenase products. Thus, development of selective lipoxygenase inhibitors and/or dual inhibitors of the cyclooxygenase and lipoxygenase pathways will provide useful tools for determining the selective roles of lipoxygenase and cyclooxygenase products in asthma and airways inflammation. In addition, these compounds will be of therapeutic interest in airways diseases.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/188</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 5-11</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/188/179</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
